Dicot Pharma
0.39 SEK
-1.28 %
Less than 1K followers
DICOT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Dicot Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -10.4 | -21.7 | -59.3 | -23.6 | -25.0 | -16.6 | -17.2 | -82.4 |
| EBIT | -10.4 | -21.7 | -59.3 | -23.6 | -24.9 | -16.6 | -17.2 | -82.4 |
| EBIT-% | ||||||||
| Profit before taxes | -10.2 | -21.7 | -57.7 | -22.9 | -24.3 | -16.1 | -16.8 | -80.2 |
| Net income | -10.2 | -20.8 | -57.7 | -22.9 | -24.3 | -16.1 | -16.8 | -80.2 |